Holm, Johanna B.
Gajer, Pawel
Ravel, Jacques
Funding for this research was provided by:
NIH National Institute of Allergy and Infectious Diseases (F32-AI136400)
National Institute of Allergy and Infectious Diseases (K01-AI163413, U19-AI158930)
Article History
Received: 8 May 2024
Accepted: 16 September 2024
First Online: 27 September 2024
Declarations
:
: Not applicable.
: Not applicable.
: JR is co-founder of LUCA Biologics, a biotechnology company focusing on translating microbiome research into live biotherapeutics drugs for women’s health. All other authors declare that they have no competing interests.